A rapid test for SARS-CoV-2 antibodies, developed by UK company Abingdon Health Ltd., has been CE-marked for professional use in the UK and EU. The company, which is part of the UK-Rapid Test Consortium (UK-RTC), also plans to gain approval for a home-use test in the coming months.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?